Because SFTPB is almost entirely bound to plasma HDL, our observations support the proposal that SFTPB carried by HDL is a marker—and perhaps mediator—of CVD risk in patients with T1DM. The gene discussed is SFTPB; the disease is type 1 diabetes mellitus.